The effects of hypertonic fluid administration on the gene expression of inflammatory mediators in circulating leucocytes in patients with septic shock: A preliminary study

Annals of Intensive Care

Volumn 1, Issue 1, 2011, Pages 1-8

  van Haren, Frank M P ^a   Sleigh, James ^b   Cursons, Ray ^c   La Pine, Mary ^b   Pickkers, Peter ^d   van der Hoeven, Johannes G ^d  

^a CANBERRA HOSPITAL   (Australia)

^b WAIKATO HOSPITAL   (New Zealand)

^c UNIVERSITY OF WAIKATO   (New Zealand)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886354156     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/2110-5820-1-44     Document Type: Article

References (37)

1. Patanwala AE, Amini A, Erstad BL: Use of hypertonic saline injection in trauma. Am J Health Syst Pharm 2010, 67:1920-1928.
2. Oliveira RP, Velasco I, Soriano F, Friedman G: Clinical review: hypertonic saline resuscitation in sepsis. Crit Care 2002, 6:418-423.
3. Rivers EP, Kruse JA, Jacobsen G, Shah K, Loomba M, Otero R, Childs EW: The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007, 35:2016-2024.
4. Dorresteijn MJ, van Eijk LT, Netea MG, Smits P, van der Hoeven JG, Pickkers P: Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia. J Endotoxin Res 2005, 11:287-293.
5. Poli-de-Figueiredo LF, Cruz RJ Jr, Sannomiya P, Rocha ESM: Mechanisms of action of hypertonic saline resuscitation in severe sepsis and septic shock. Endocr Metab Immune Disord Drug Targets 2006, 6:201-206.
6. Kolsen-Petersen JA: Immune effect of hypertonic saline: fact or fiction? Acta Anaesthesiol Scand 2004, 48:667-678.
7. Angle N, Cabello-Passini R, Hoyt DB, Loomis WH, Shreve A, Namiki S, Junger WG: Hypertonic saline infusion: can it regulate human neutrophil function? Shock 2000, 14:503-508.
8. Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265:808-811.
9. Ciesla DJ, Moore EE, Gonzalez RJ, Biffl WL, Silliman CC: Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. Shock 2000, 14:265-269, discussion 269-270.
10. Cabioglu N, Bilgic S, Deniz G, Aktas E, Seyhun Y, Turna A, Gunay K, Esen F: Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis. Arch Surg 2002, 137:1037-1043, discussion 1043.
11. Kalkoff M, Cursons RT, Sleigh JW, Jacobson GM: The use of real time rtPCR to quantify inflammatory mediator expression in leukocytes from patients with severe sepsis. Anaesth Intensive Care 2004, 32:746-755.
12. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003,29:530-538.
13. Mane VP, Heuer MA, Hillyer P, Navarro MB, Rabin RL: Systematic method for determining an ideal housekeeping gene for real-time PCR analysis. J Biomol Tech 2008, 19:342-347.
14. Stamova BS, Apperson M, Walker WL, Tian Y, Xu H, Adamczy P, Zhan X, Liu DZ, Ander BP, Liao IH, et al: Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med Genomics 2009, 2:49.
15. Ramakers C, Ruijter JM, Deprez RH, Moorman AF: Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003, 339:62-66.
16. Wilkening S, Bader A: Quantitative real-time polymerase chain reaction:methodical analysis and mathematical model. J Biomolecular Tech 2004, 15:107-111.
17. Sutherland AM, Walley KR: Bench-to-bedside review: association of genetic variation with sepsis. Crit Care 2009, 13:210.
18. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993, 103:565-575.
19. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC: Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007, 167:1655-1663.
20. Lin KJ, Lin J, Hanasawa K, Tani T, Kodama M: Interleukin-8 as a predictor of the severity of bacteremia and infectious disease. Shock 2000, 14:95-100.
21. Kramer GC: Hypertonic resuscitation: physiologic mechanisms and recommendations for trauma care. J Trauma 2003, 54:S89-S99.
22. Lv R, Zhou W, Zhang LD, Xu JG: Effects of hydroxyethyl starch on hepatic production of cytokines and activation of transcription factors in lipopolysaccharide-administered rats. Acta Anaesthesiol Scand 2005, 49:635-642.
23. Yassen KA, Galley HF, Webster NR: Matrix metalloproteinase-9 concentrations in critically ill patients. Anaesthesia 2001, 56:729-732.
24. Nakamura T, Ebihara I, Shimada N, Shoji H, Koide H: Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment. Am J Med Sci 1998, 316:355-360.
25. Pascual JL, Ferri LE, Seely AJ, Campisi G, Chaudhury P, Giannias B, Evans DC, Razek T, Michel RP, Christou NV: Hypertonic saline resuscitation of hemorrhagic shock diminishes neutrophil rolling and adherence to endothelium and reduces in vivo vascular leakage. Ann Surg 2002, 236:634-642.
26. Corso CO, Okamoto S, Leiderer R, Messmer K: Resuscitation with hypertonic saline dextran reduces endothelial cell swelling and improves hepatic microvascular perfusion and function after hemorrhagic shock. J Surg Res 1998, 80:210-220.
27. Mazzoni MC, Borgstrom P, Intaglietta M, Arfors KE: Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock 1990, 31:407-418.
28. Finger EB, Puri KD, Alon R, Lawrence MB, von Andrian UH, Springer TA: Adhesion through L-selectin requires a threshold hydrodynamic shear.Nature 1996, 379:266-269.
29. Yada-Langui MM, Anjos-Valotta EA, Sannomiya P, Rocha e Silva M, Coimbra R: Resuscitation affects microcirculatory polymorphonuclear leukocyte behavior after hemorrhagic shock: role of hypertonic saline and pentoxifylline. Exp Biol Med (Maywood) 2004, 229:684-693.
30. Angle N, Hoyt DB, Cabello-Passini R, Herdon-Remelius C, Loomis W, Junger WG: Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. J Trauma 1998, 45:7-12, discussion 12-13.
31. Deitch EA, Shi HP, Feketeova E, Hauser CJ, Xu DZ: Hypertonic saline resuscitation limits neutrophil activation after trauma-hemorrhagic shock. Shock 2003, 19:328-333.
32. Alon R, Ley K: Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol 2008, 20:525-532.
33. Thelen M, Stein JV: How chemokines invite leukocytes to dance. Nat Immunol 2008, 9:953-959.
34. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD: Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol 1998, 161:6288-6296.
35. Rizoli SB, Kapus A, Parodo J, Fan J, Rotstein OD: Hypertonic immunomodulation is reversible and accompanied by changes in CD11b expression. J Surg Res 1999, 83:130-135.
36. Rizoli SB, Rhind SG, Shek PN, Inaba K, Filips D, Tien H, Brenneman F, Rotstein O: The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial. Ann Surg 2006, 243:47-57.
37. Ciesla DJ, Moore EE, Zallen G, Biffl WL, Silliman CC: Hypertonic saline attenuation of polymorphonuclear neutrophil cytotoxicity: timing is everything. J Trauma 2000, 48:388-395.